CYSTEINYL-LEUKOTRIENE RECEPTOR ANTAGONIST, BRONCHOCONSTRICTION, AND AIRWAY HYPERREACTIVITY

被引：6
|
作者：
AALBERS, R
DEMONCHY, JGR
机构：
来源：
LANCET | 1991年 / 338卷 / 8764期
关键词：
D O I：
10.1016/0140-6736(91)91067-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：445 / 445
页数：1
相关论文
共 50 条
  • [21] BENEFICIAL EFFECTS MONTELUKAST WHICH IS CYSTEINYL-LEUKOTRIENE RECEPTOR ANTAGONIST ON RENAL DAMAGE AFTER UNILATERAL URETERAL OBSTRUCTION IN RATS
    Otunctemur, Alper
    Cakir, Suleyman Sami
    Dursun, Murat
    Polat, Emre Can
    Somay, Adnan
    Ozbay, Nurver
    Cekmen, Mustafa
    Ozbek, Emin
    JOURNAL OF ENDOUROLOGY, 2012, 26 : A1 - A1
  • [22] Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice
    Shimbori, Chiko
    Shiota, Naotaka
    Okunishi, Hideki
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 650 (01) : 424 - 430
  • [23] Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone
    Murai, A
    Abe, M
    Hayashi, Y
    Sakata, N
    Katsuragi, T
    Tanaka, K
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 312 (02): : 432 - 440
  • [24] Arachidonic acid inhibits cysteinyl-leukotriene receptor activation in human pulmonary vessels
    Walch, L
    Norel, X
    Gascard, JP
    Brink, C
    ADVANCES IN PROSTAGLANDIN, LEUKOTRIENE, AND OTHER BIOACTIVE LIPID RESEARCH: BASIC SCIENCE AND CLINICAL APPLICATIONS, 2003, 525 : 75 - 79
  • [25] Protective effect of pranlukast, a cysteinyl-leukotriene receptor 1 antagonist, on indomethacin-induced small intestinal damage in rats
    H. Nishio
    Y. Hayashi
    S. Terashima
    K. Takeuchi
    Inflammopharmacology, 2008, 16 (2) : 106 - 106
  • [26] Protective effect of pranlukast, a cysteinyl-leukotriene receptor 1 antagonist, on indomethacin-induced small intestinal damage in rats
    Nishio H.
    Hayashi Y.
    Terashima S.
    Takeuchi K.
    Inflammopharmacology, 2007, 15 (6) : 266 - 272
  • [27] Montelukast: More than a Cysteinyl Leukotriene Receptor Antagonist?
    Tintinger, Gregory R.
    Feldman, Charles
    Theron, Annette J.
    Anderson, Ronald
    THESCIENTIFICWORLDJOURNAL, 2010, 10 : 2403 - 2413
  • [28] Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects
    Hamilton, A
    Faiferman, I
    Stober, P
    Watson, RM
    O'Byrne, PM
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 102 (02) : 177 - 183
  • [29] Cysteinyl-leukotriene receptor antagonism blunts the acute hypotensive response to endotoxin in cats
    DeClue, Amy E.
    Sharp, Claire R.
    Cohen, Rachael L.
    Leverenz, Elizabeth F.
    Reinero, Carol R.
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2010, 12 (10) : 754 - 759
  • [30] The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model
    M Hamdi Muz
    Figen Deveci
    Yasemin Bulut
    Nevin Ilhan
    Hayrettin Yekeler
    Teyfik Turgut
    Experimental & Molecular Medicine, 2006, 38 : 109 - 118
12345